Arizona's Opioid Crisis: Understanding the Epidemic and Finding Treatment

The Scope of the Opioid Crisis in Arizona

Arizona declared a public health emergency related to opioids in June 2017, and the crisis has only deepened in the years since. What began as an epidemic driven by prescription painkillers in the early 2000s evolved into a heroin crisis and then, beginning around 2018, was overtaken by illicit fentanyl. Today, fentanyl is involved in approximately 75 percent of all opioid-related overdose deaths in Arizona, and the drug has fundamentally changed the risk profile of substance use across the state.

Maricopa County, home to Phoenix and its suburbs, bears a disproportionate share of Arizona's opioid burden. The county reported over 2,800 suspected opioid deaths in 2024, more than all other Arizona counties combined. Hotspots for overdose activity include south and west Phoenix, the area along the I-17 corridor south of downtown, and portions of Mesa and Tempe in the East Valley. The crisis affects every demographic, but data from the Maricopa County Medical Examiner shows that men between 25 and 54 are the most heavily impacted group.

The human cost of this crisis extends far beyond the death toll. Thousands of Arizona families have been fractured by opioid addiction. Children enter the foster care system because their parents cannot provide safe homes. Emergency departments at hospitals like Banner University Medical Center, Valleywise Health (formerly Maricopa Medical Center), and HonorHealth are strained by the volume of overdose cases. First responders, particularly along the I-10 and I-17 corridors, administer naloxone with increasing frequency.

How We Got Here: The Evolution of Arizona's Opioid Epidemic

Understanding the history of the opioid epidemic in Arizona helps contextualize the current crisis and informs the most effective approaches to treatment. The epidemic is widely described in three waves. The first wave, beginning in the late 1990s, was driven by the overprescription of opioid painkillers like OxyContin, Vicodin, and Percocet. Arizona, like much of the Southwest, saw a dramatic increase in opioid prescriptions during this period, with rural and tribal communities hit particularly hard.

The second wave arrived around 2010 as prescription opioid users, facing tighter prescribing regulations and higher street prices, transitioned to heroin. Phoenix's proximity to the US-Mexico border made heroin readily available and inexpensive. Distribution networks along the I-10 and I-17 corridors brought heroin into neighborhoods across the metro area. Overdose deaths involving heroin surged throughout the 2010s.

The third and current wave, driven by illicit fentanyl and its analogs, began accelerating around 2018. Fentanyl is 50 to 100 times more potent than morphine and is now mixed into or sold as virtually every type of street drug. The Sinaloa and Jalisco New Generation cartels have industrialized fentanyl production, and Arizona's border location makes it a primary entry point. This third wave has been the deadliest, overwhelming the progress made in reducing prescription opioid misuse.

Medication-Assisted Treatment: The Gold Standard for Opioid Use Disorder

Medication-assisted treatment (MAT) combines FDA-approved medications with behavioral therapy and counseling to treat opioid use disorder. Decades of research and the consensus of every major medical organization, including the American Medical Association, the American Society of Addiction Medicine, and the World Health Organization, support MAT as the most effective treatment for opioid addiction. MAT reduces overdose deaths by up to 50 percent and significantly improves retention in treatment, employment, and social functioning.

Despite this overwhelming evidence, MAT remains underutilized in Arizona and nationwide. Stigma, both from the general public and within some segments of the treatment and recovery community, continues to be a barrier. Some treatment facilities and sober living homes in the Phoenix area still do not accept individuals on MAT medications, which is medically inappropriate and potentially dangerous. When choosing a treatment provider, always confirm that they support and provide MAT as part of their clinical programming.

Naloxone Access and Harm Reduction in Arizona

Naloxone (brand name Narcan) is a life-saving medication that rapidly reverses opioid overdoses. In 2017, Arizona Governor Doug Ducey issued an executive order that enabled naloxone to be dispensed by pharmacists without an individual prescription, significantly expanding access. Since then, Arizona has distributed hundreds of thousands of naloxone doses through pharmacies, community organizations, and harm reduction programs.

In the Phoenix metro area, naloxone is available at most major pharmacies including CVS, Walgreens, and Walmart. Community organizations like Sonoran Prevention Works distribute naloxone kits free of charge at events and through their offices. The Maricopa County Department of Public Health also provides naloxone through its overdose prevention programs. If you or someone you know uses opioids, carrying naloxone is an essential safety measure.

Broader harm reduction strategies, including fentanyl test strips, safe use education, and syringe services, have faced more resistance in Arizona than naloxone distribution. However, advocacy organizations continue to push for expanded harm reduction access, and some programs operate in the Phoenix area. These services save lives and connect people to treatment when they are ready.

Treatment Pathways for Opioid Addiction in the Phoenix Area

Effective treatment for opioid use disorder typically begins with medical stabilization, either through a formal detox program or through the initiation of MAT in an outpatient setting. The appropriate starting point depends on the severity of the addiction, the individual's medical history, co-occurring conditions, and social stability. A clinical assessment, which can be obtained through most treatment facilities, emergency departments, or primary care providers, will help determine the right level of care.

For individuals with severe opioid use disorder, active intravenous use, or significant co-occurring conditions, residential treatment followed by step-down to outpatient care is often the most effective pathway. The structured environment of residential treatment allows for medical stabilization, MAT initiation, intensive therapy, and development of a comprehensive aftercare plan. Programs along the I-17 corridor and in the East Valley offer residential opioid treatment with MAT integration.

For those with less severe presentations or strong social support systems, outpatient treatment with MAT can be initiated directly through clinics and prescribers across the metro area. SAMHSA's online treatment locator (findtreatment.gov) includes a filter for buprenorphine practitioners and OTPs in the Phoenix area. AHCCCS members can also contact Mercy Care for referrals to in-network opioid treatment providers.

Arizona's Response: State Programs and Policy Initiatives

Arizona has implemented a multi-pronged response to the opioid crisis through legislation, public health programs, and enforcement actions. The Arizona Opioid Epidemic Act, signed in 2018, imposed limits on initial opioid prescriptions, required electronic prescribing, mandated continuing education for prescribers, and expanded Good Samaritan protections for individuals who call 911 during an overdose. These measures have contributed to a significant reduction in opioid prescribing rates, though they have not fully addressed the illicit fentanyl crisis.

The Arizona Department of Health Services operates the Opioid Assistance and Referral (OAR) Line at 1-888-688-4222, which provides 24/7 support for individuals seeking opioid treatment resources. The state has also invested in expanding MAT access in underserved areas, including tribal communities and rural counties. Arizona's opioid settlement funds, received from pharmaceutical company lawsuits, are being directed toward treatment expansion, naloxone distribution, and prevention programs.

Seeking Treatment Beyond Arizona: Specialized Opioid Programs in Southern California

While Arizona has made significant strides in expanding opioid treatment access, some individuals find that local options do not meet their specific needs. Common reasons for seeking out-of-state treatment include previous unsuccessful attempts at local programs, a desire for geographic separation from drug use environments, interest in specialized treatment modalities not widely available in Phoenix, and the need for a completely fresh start.

Southern California, and Orange County in particular, is home to numerous treatment facilities that specialize in opioid use disorder with integrated MAT programming. Trust SoCal, located at 16537 Elm Cir, Fountain Valley, CA 92708, offers comprehensive opioid treatment that includes medical detox, MAT initiation and management, evidence-based behavioral therapies, and robust aftercare planning. The facility works with many major insurance carriers and can help Arizona residents navigate the logistics of out-of-state treatment.

For Phoenix-area residents considering treatment in Southern California, the transition is straightforward. Direct flights from Phoenix Sky Harbor to John Wayne Airport (SNA) take approximately 75 minutes. Trust SoCal coordinates airport pickups and admission logistics for out-of-state clients. To discuss whether out-of-state opioid treatment is right for your situation, call (949) 280-8360 for a confidential assessment.